- Home
- MDCX vs GRABW Comparison
MDCX vs GRABW Comparison
Compare MDCX & GRABW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDCX
- GRABW
- Stock Information
- Founded
- MDCX 2008
- GRABW 2012
- Country
- MDCX United States
- GRABW Singapore
- Employees
- MDCX N/A
- GRABW 11267
- Industry
- MDCX
- GRABW Business Services
- Sector
- MDCX
- GRABW Consumer Discretionary
- Exchange
- MDCX Nasdaq
- GRABW Nasdaq
- Market Cap
- MDCX 36.2M
- GRABW N/A
- IPO Year
- MDCX N/A
- GRABW N/A
- Fundamental
- Price
- MDCX $2.41
- GRABW $0.49
- Analyst Decision
- MDCX Strong Buy
- GRABW
- Analyst Count
- MDCX 2
- GRABW 0
- Target Price
- MDCX $23.50
- GRABW N/A
- AVG Volume (30 Days)
- MDCX 369.0K
- GRABW 54.7K
- Earning Date
- MDCX 08-11-2025
- GRABW 02-21-2025
- Dividend Yield
- MDCX N/A
- GRABW N/A
- EPS Growth
- MDCX N/A
- GRABW N/A
- EPS
- MDCX N/A
- GRABW N/A
- Revenue
- MDCX N/A
- GRABW $2,686,000,000.00
- Revenue This Year
- MDCX N/A
- GRABW N/A
- Revenue Next Year
- MDCX N/A
- GRABW N/A
- P/E Ratio
- MDCX N/A
- GRABW N/A
- Revenue Growth
- MDCX N/A
- GRABW 21.65
- 52 Week Low
- MDCX $1.79
- GRABW $0.15
- 52 Week High
- MDCX $8.94
- GRABW $0.59
- Technical
- Relative Strength Index (RSI)
- MDCX 54.84
- GRABW 66.31
- Support Level
- MDCX $2.00
- GRABW $0.43
- Resistance Level
- MDCX $2.11
- GRABW $0.55
- Average True Range (ATR)
- MDCX 0.20
- GRABW 0.05
- MACD
- MDCX 0.09
- GRABW 0.02
- Stochastic Oscillator
- MDCX 68.89
- GRABW 69.54
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
About GRABW Grab Holdings Limited Warrant
Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore, Indonesia, and Malaysia contributed more than 70% of revenue in 2024. Grab's main competitors in Southeast Asia are Line Man and Goto. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.